{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:08:55Z","timestamp":1790683735406,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Dental Journal"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.identj.2026.109652","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:21:35Z","timestamp":1781601695000},"page":"109652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Drug Associated Factors for Gingival Disorders: A Real-World Pharmacovigilance Study"],"prefix":"10.1016","volume":"76","author":[{"given":"Qi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.identj.2026.109652_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057768","article-title":"Effect of systemic bisphosphonate administration on patients with periodontal disease: a systematic review and meta-analysis protocol","volume":"12","author":"Koide","year":"2022","journal-title":"BMJ Open"},{"issue":"Suppl 20","key":"10.1016\/j.identj.2026.109652_bib0002","first-page":"S28","article-title":"Non-plaque-induced gingival diseases","volume":"45","author":"Holmstrup","year":"2018","journal-title":"J Clin Periodontol"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/prd.12450","article-title":"Illegal drugs and periodontal conditions","volume":"90","author":"Quaranta","year":"2022","journal-title":"Periodontol 2000"},{"issue":"5","key":"10.1016\/j.identj.2026.109652_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.100906","article-title":"National Pharmacovigilance Assessment of oral adverse events following COVID-19 vaccination in Germany (2020-2023)","volume":"75","author":"Riad","year":"2025","journal-title":"Int Dent J"},{"issue":"7","key":"10.1016\/j.identj.2026.109652_bib0005","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"7","author":"Beth-Tasdogan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.identj.2026.109652_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1435054","article-title":"Cytokines in gingivitis and periodontitis: from pathogenesis to therapeutic targets","volume":"15","author":"Neurath","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0007","first-page":"52","article-title":"Proliferative and inductive effects of Cyclosporine a on gingival fibroblast of child and adult","volume":"10","author":"Salman","year":"2013","journal-title":"Dent Res J (Isfahan)"},{"issue":"5","key":"10.1016\/j.identj.2026.109652_bib0008","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/jre.12761","article-title":"Galectin-8 mediates fibrogenesis induced by cyclosporine in human gingival fibroblasts","volume":"55","author":"Smith","year":"2020","journal-title":"J Periodontal Res"},{"issue":"5","key":"10.1016\/j.identj.2026.109652_bib0009","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.identj.2026.109652_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101967","article-title":"Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database","volume":"59","author":"Zhou","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.identj.2026.109652_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.103957","article-title":"Identification of drugs associated with oral ulcers based on pharmacovigilance","volume":"75","author":"Zhang","year":"2025","journal-title":"Int Dent J"},{"key":"10.1016\/j.identj.2026.109652_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1338902","article-title":"Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database","volume":"15","author":"Zou","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0013","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41368-023-00244-1","article-title":"Double heterozygous pathogenic mutations in KIF3C and ZNF513 cause hereditary gingival fibromatosis","volume":"15","author":"Chen","year":"2023","journal-title":"Int J Oral Sci"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0014","first-page":"71","article-title":"Necrotizing periodontal diseases in HIV-infected Brazilian patients: a clinical and microbiologic descriptive study","volume":"43","author":"Ramos","year":"2012","journal-title":"Quintessence Int"},{"issue":"7","key":"10.1016\/j.identj.2026.109652_bib0015","first-page":"394","article-title":"Plasma cell gingivitis: does it exist? Report of a case and review of the literature","volume":"63","author":"Jadwat","year":"2008","journal-title":"SADJ"},{"issue":"10","key":"10.1016\/j.identj.2026.109652_bib0016","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1248\/bpb.28.1817","article-title":"Drug-induced gingival overgrowth\u2013a review","volume":"28","author":"Kataoka","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/prd.12380","article-title":"Frailty, aging, and periodontal disease: basic biologic considerations","volume":"87","author":"Clark","year":"2021","journal-title":"Periodontol 2000"},{"issue":"2","key":"10.1016\/j.identj.2026.109652_bib0018","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jre.12298","article-title":"Sex dimorphism in periodontitis in animal models","volume":"51","author":"Duan","year":"2016","journal-title":"J Periodontal Res"},{"issue":"6","key":"10.1016\/j.identj.2026.109652_bib0019","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.oraloncology.2011.03.028","article-title":"Oral complications of targeted cancer therapies: a narrative literature review","volume":"47","author":"Watters","year":"2011","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.identj.2026.109652_bib0021","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1065-6995(03)00125-2","article-title":"Tyrosine phosphorylation is involved in Ca(2+)entry in human gingival fibroblasts","volume":"27","author":"Ogata","year":"2003","journal-title":"Cell Biol Int"},{"issue":"Suppl5","key":"10.1016\/j.identj.2026.109652_bib0022","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.identj.2026.109652_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309189","article-title":"Cyclosporine A causes gingival overgrowth via reduced G1 cell cycle arrest in gingival fibroblasts","volume":"19","author":"Takeuchi","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.identj.2026.109652_bib0024","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/biomedicines8070221","article-title":"Drug-induced gingival overgrowth: the effect of Cyclosporin A and mycophenolate mophetil on human gingival fibroblasts","volume":"8","author":"Lauritano","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtha.2024.09.022","article-title":"Management of antithrombotic therapy in patients undergoing dental procedures","volume":"23","author":"Curtis","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.identj.2026.109652_bib0026","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00003086-200003000-00016","article-title":"Osteoporosis","volume":"372","author":"Lane","year":"2000","journal-title":"Clin Orthop Relat Res"},{"issue":"21","key":"10.1016\/j.identj.2026.109652_bib0027","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0028","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1038\/s41598-022-11615-9","article-title":"A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients","volume":"12","author":"Jung","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.identj.2026.109652_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1111627","article-title":"Augmentation of IFN-\u03b3 by bone marrow derived immune cells in the presence of severe suppression of IFN-\u03b3 in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ","volume":"14","author":"Kaur","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.identj.2026.109652_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","article-title":"Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice","volume":"28","author":"Kobayashi","year":"2010","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"10.1016\/j.identj.2026.109652_bib0031","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/odi.12651","article-title":"Phenytoin-induced gingival overgrowth caused by death receptor pathway malfunction","volume":"23","author":"Takeuchi","year":"2017","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.identj.2026.109652_bib0032","first-page":"1287","article-title":"Phenytoin activates Smad3 phosphorylation and periostin expression in drug-induced gingival enlargement","volume":"33","author":"Kim","year":"2018","journal-title":"Histol Histopathol"},{"issue":"21","key":"10.1016\/j.identj.2026.109652_bib0033","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.3390\/ijerph17218229","article-title":"Drug-induced gingival overgrowth: a pilot study on the effect of diphenylhydantoin and gabapentin on human gingival fibroblasts","volume":"17","author":"Lauritano","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.identj.2026.109652_bib0034","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cap.10123","article-title":"Lamotrigine-induced gingival enlargement: an older problem due to a newer drug - a rare case report","volume":"12","author":"Rajendran","year":"2022","journal-title":"Clin Adv Periodontics"},{"key":"10.1016\/j.identj.2026.109652_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200672","article-title":"Global developmental delay with sodium valproate-induced gingival hyperplasia","volume":"2014","author":"Patil","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.identj.2026.109652_bib0036","first-page":"212","article-title":"Severe anti-epileptic drug-induced gingival overgrowth in a physically disabled patient","volume":"65","author":"Kaomongkolgit","year":"2015","journal-title":"West Indian Med J"},{"issue":"2","key":"10.1016\/j.identj.2026.109652_bib0037","first-page":"925","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support Care Cancer"}],"container-title":["International Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0020653926002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:44:43Z","timestamp":1790682283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0020653926002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0020653926002455"],"URL":"https:\/\/doi.org\/10.1016\/j.identj.2026.109652","relation":{},"ISSN":["0020-6539"],"issn-type":[{"value":"0020-6539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Drug Associated Factors for Gingival Disorders: A Real-World Pharmacovigilance Study","name":"articletitle","label":"Article Title"},{"value":"International Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.identj.2026.109652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of FDI World Dental Federation.","name":"copyright","label":"Copyright"}],"article-number":"109652"}}